AstraZeneca will acquire Alexion Pharmaceuticals in $39 billion push into rare diseases and immunologyMarket Watch • 12/14/20
Alexion Pharmaceuticals soars 35% after AstraZeneca agrees to $39 billion takeoverBusiness Insider • 12/14/20
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billionCNN Business • 12/12/20
AstraZeneca is acquiring Alexion Pharmaceuticals in a $39 billion pharmaceutical dealBusiness Insider • 12/12/20
AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial DevelopmentBusiness Wire • 12/12/20
AstraZeneca will work with the makers of Russia's Sputnik V vaccine to test a combined shot. This could make people more immune, and for a longer period of time, it said.Business Insider • 12/11/20
India Is Reportedly Seeking More Data On Oxford-AstraZeneca Vaccine Before Granting Emergency AuthorizationForbes • 12/09/20
Oxford-AstraZeneca Covid vaccine to immunize the planet 'more effectively,' Lancet editor saysCNBC • 12/09/20
After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?The Motley Fool • 12/09/20
AstraZeneca Says Vaccine Blocks Severe Covid-19; Shares Edge HigherInvestors Business Daily • 12/08/20